There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Sanofi (SNYNF – Research Report) and Encompass Health (EHC – Research Report) with bullish sentiments.
Sanofi (SNYNF)
In a report released today, Graham Parry from Bank of America Securities maintained a Buy rating on Sanofi, with a price target of $72.00. The company’s shares closed last Wednesday at $108.00, close to its 52-week high of $114.90.
Parry has an average return of
According to TipRanks.com, Parry is ranked #3095 out of 8548 analysts.
Sanofi has an analyst consensus of Moderate Buy, with a price target consensus of $109.11, which is a 1.0% upside from current levels. In a report issued on September 26, Citi also maintained a Buy rating on the stock with a EUR138.00 price target.
See today’s best-performing stocks on TipRanks >>
Encompass Health (EHC)
Bank of America Securities analyst Kevin Fischbeck maintained a Buy rating on Encompass Health today and set a price target of $84.00. The company’s shares closed last Wednesday at $67.11.
According to TipRanks.com, Fischbeck is a 3-star analyst with an average return of
Currently, the analyst consensus on Encompass Health is a Strong Buy with an average price target of $79.56.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on SNYNF:
- Syneos Health appoints Terttu Haring as president, clinical sites & patients
- Regeneron, Sanofi announce FDA acceptance for Priority Review of Dupixent sBLA
- Sanofi price target raised to EUR 108 from EUR 100 at Morgan Stanley
- Sanofi says once-weekly Altuviiio approved in Japan
- MacroGenics, Aventis mutually terminate Royalty Purchase Agreement
